Arendrup M, Nielsen C, Hansen J E, Pedersen C, Mathiesen L, Nielsen J O
Department of Infectious Diseases, Hvidovre Hospital, University of Copenhagen, Denmark.
J Acquir Immune Defic Syndr (1988). 1992;5(3):303-7.
The capacity of consecutive human sera to neutralize sequentially obtained autologous virus isolates was studied. HIV-1 was isolated three times over a 48-164-week period from three individuals immediately after seroconversion and from two individuals in later stages of infection. Development of neutralizing antibodies to the primary virus isolates was detected 13-45 weeks after seroconversion. Emergence of escape virus with reduced sensitivity to neutralization by autologous sera was demonstrated. The patients subsequently developed neutralizing antibodies against the escape virus but after a delay. Titers of neutralizing antibodies against late virus isolates were generally low compared to initial neutralizing titers against primary virus isolates. The delay in appearance of neutralizing antibodies to the dominant viral strain at any time in the patient and the emergence of neutralization resistant escape virus may be part of the explanation of the apparent failure of the immune system to control HIV infection.
研究了连续采集的人血清对依次获得的自体病毒分离株的中和能力。在血清转化后立即从三名个体以及感染后期的两名个体中,于48 - 164周期间三次分离出HIV-1。在血清转化后13 - 45周检测到针对原始病毒分离株的中和抗体的产生。证明出现了对自体血清中和敏感性降低的逃逸病毒。患者随后产生了针对逃逸病毒的中和抗体,但有所延迟。与针对原始病毒分离株的初始中和滴度相比,针对晚期病毒分离株的中和抗体滴度通常较低。患者在任何时候针对优势病毒株的中和抗体出现延迟以及中和抗性逃逸病毒的出现,可能部分解释了免疫系统明显无法控制HIV感染的原因。